Regulatory news and experts insights.

In response to the public health and environmental challenges posed by endocrine disruptors (EDs), and following two previous national strategies on endocrine disruptors, the French government has unveiled its new roadmap for the next five years with a clear ambition: moving towards “zero exposure to endocrine disruptors”.

The identification of endocrine disruptors (EDs) has become a key challenge for many industries. With increasing regulatory requirements and the growing number of substance lists evaluated by authorities, obtaining a clear and rapid overview of a substance’s status has become increasingly complex.

In recent years, few regulatory topics have attracted as much attention as endocrine disruptors, chemicals capable of interfering with hormone systems in humans and wildlife. Their potential effects on development, reproduction, and environmental health have prompted increasingly rigorous scrutiny across the globe.